Vivacta Biotechnology
Latest round
- Series A
Last raised
- Apr 2026
Total raised
- Undisclosed
Investors
- 9
About Vivacta Biotechnology
, trading as Vivacta Biotechnology, conducts research and development in cell and gene technology, supported by collaborations across the medical and scientific communities. The company also engages in international trade and technology consulting to promote global cooperation in biotechnology applications. Weitao Biotechnology’s business scope includes biotechnology R&D, medical research, and the development of human stem cell and gene-related technologies. The company provides technical services and solutions that support healthcare innovation and life science advancement, with potential applications in disease treatment, regenerative medicine, and genetic analysis. The company generates revenue from biotechnology research services, technology transfer, and the commercialization of gene and cell technology solutions, along with consulting and trade-related activities in the biomedical sector.
Who invested in Vivacta Biotechnology
9 investors across 2 rounds
See all investors in Vivacta Biotechnology
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Vivacta Biotechnology
Who invested in Vivacta Biotechnology?
Vivacta Biotechnology has 9 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Vivacta Biotechnology raised?
Vivacta Biotechnology has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Vivacta Biotechnology last raise money?
Vivacta Biotechnology's most recent round on record is a Series A, in Apr 2026.
What does Vivacta Biotechnology do?
, trading as Vivacta Biotechnology, conducts research and development in cell and gene technology, supported by collaborations across the medical and scientific communities.
Where is Vivacta Biotechnology headquartered?
Vivacta Biotechnology is headquartered in Shanghai, China.
Which VCs invest in companies like Vivacta Biotechnology?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Vivacta Biotechnology's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Vivacta Biotechnology? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.